Combination preparation of estrogen and prostaglandin
US4094977A · kind A · utility
5Cited by
0References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 24, 1976 |
| Grant date | Jun 13, 1978 |
| Priority date | — |
| Expiry date | Jun 24, 1996 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/557
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical combination preparation which comprises as active substances at least one compound selected from the group of the luteolytically effective prostaglandins or derivatives thereof and at least one compound selected from the group of the estrogenic substances, in a weight ratio of from 1:1 to 1:5,000, in admixture with the usual adjuvants and/or carrier material.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.